(Q40433308)

20 September 2017

1 reference

title

Immunity to oncogenic proteins (English)

1 reference

20 September 2017

Cheever MA

1

1 reference

20 September 2017

Disis ML

2

1 reference

20 September 2017

Bernhard H

3

1 reference

20 September 2017

Gralow JR

4

1 reference

20 September 2017

Hand SL

5

1 reference

20 September 2017

Huseby ES

6

1 reference

20 September 2017

Qin HL

7

1 reference

20 September 2017

Takahashi M

8

1 reference

20 September 2017

Chen W

9

1 reference

20 September 2017

1 June 1995

1 reference

20 September 2017

Immunological Reviews

1 reference

20 September 2017

145

1 reference

20 September 2017

33-59

1 reference

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Using a neural network to identify potential HLA-DR1 binding sites within proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Biological and biochemical properties of human rasH genes mutated at codon 61.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Identifying antigenic T-cell sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Cancer antigens: immune recognition of self and altered self

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

T cell recognition of human tumors: implications for molecular immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

The role of erbB-2 and its ligands in growth control of malignant breast epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Biological properties of human c-Ha-ras1 genes mutated at codon 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Antibody recognition of the tumor-specific bcr-abl joining region in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Prevalence of ras gene mutations in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

10.1111/J.1600-065X.1995.TB00076.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference